The entry of HIV-1 into host cells is mediated by precise interactions between viral envelope glycoproteins and cellular receptors. Fusion inhibitors, which disrupt these interactions—particularly by ...
Enfuvirtide used as a single agent was originally studied in 17 HIV-infected patients. [8] Seven of these individuals had not previously been exposed to antiretrovirals, and 10 had been previously ...